Analyst Ratings For NASDAQ:CDMO – Avid Bioservices (NASDAQ:CDMO)
Today, HC Wainwright initiated coverage on NASDAQ:CDMO – Avid Bioservices (NASDAQ:CDMO) with a Buy with a price target of $5.00.
Some recent analyst ratings include
- 5/24/2018-HC Wainwright initiated coverage with a Buy rating.
- 3/15/2018-Wells Fargo & Co initiated coverage with a Outperform rating.
- 3/13/2018-First Analysis initiated coverage with a Overweight rating.
- 1/5/2018-Noble Financial Reiterated Rating of Buy.
- 9/13/2016-Roth Capital Reiterated Rating of Neutral.
- 9/12/2016-FBR & Co Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:CDMO – Avid Bioservices (NASDAQ:CDMO)
NASDAQ:CDMO – Avid Bioservices (NASDAQ:CDMO) has insider ownership of 2.53% and institutional ownership of 19.00%.
- On 2/15/2018 Mark R Bamforth, Director, bought 50,000 with an average share price of $2.25 per share and the total transaction amounting to $112,500.00.
Recent Trading Activity for NASDAQ:CDMO – Avid Bioservices (NASDAQ:CDMO)
Shares of NASDAQ:CDMO – Avid Bioservices closed the previous trading session at 3.63 up +0.07 1.97% with shares trading hands.